Dr. Candida Fratazzi has worked in biomedical research for over 25 years. Prior to her full commitment to Boston Biotech Clinical Research, LLC, she served as Senior Medical Program Leader at Altus Pharmaceuticals Inc., Shire HGT, and Vitex Inc. Dr. Fratazzi has also held management positions at Johnson & Johnson Pharmaceuticals and Wyeth Pharmaceuticals. During her carrier, Dr. Fratazzi developed clinical strategies and plan developments for many drug candidates, presented in INDs and end-of-phase2 briefing documents.
Read the full bio

Dr. Claudio Carini currently serves as Chief Medical Officer and Vice President for Clinical Research at Fresenius Pharmaceuticals Before joining Fresenius, Dr. Carini was Global Head of Translational Medicine and Head of The Biomarker Alliance at MDS Pharma. Prior to joining MDS, he served as Global Head of Biomarkers at Hoffman La Roche, and before that as Global Director and Therapeutic Area Head of Translational Medicine at Novartis.
Read the full bio

Dr. John Morrow has more than 30 years experience as an investigative scientist in the fields of immunology, rheumatology and microbiology. In addition to basic research he has also run a clinical reference laboratory (diagnostic immunology, University of London) and has extensive experience of product applications and development within the biopharmaceutical industry.
Read the full bio

Strategically-focused marketing/sales executive and trusted leader with a deep command of all core business practices in the medical device and biotech services industries. Proactive clinical strategist and pacesetter – propelling revenues through effective sales and marketing management across start-up and high-growth organizations.
Read the full bio

Dr. Paul Martha former President and CEO for Clinical Development & Regulatory Affairs at Elixir Pharmaceuticals in Cambridge, MA. Before joining Elixir, Dr. Martha was Executive Vice President of Research and Development at Chiasma, Inc., a privately-held biopharmaceutical company based in Jerusalem, Israel. Prior to Chiasma, Dr. Martha held the position of Chief Medical Officer and Senior Vice President of Shire Human Genetic Therapies, formerly Transkaryotic Therapies, Inc. (TKT).
Read the full bio

For the past 33 Years Dr. Fuchs has held major Operations Management positions in the Biotechnology and Pharmaceutical Industry. Dr. Fuchs has developed the Process Development and Manufacturing Organizations in a number of companies. In doing so, he has managed technology development, technology transfer and implementation and finally the manufacturing and CMC regulatory approvals of pharmaceutical products worldwide.
Read the full bio